We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





KUKA Introduces Innovative Medical Robots for the Operating Room (OR) at MEDICA 2021

By LabMedica International staff writers
Posted on 15 Nov 2021
KUKA AG (Augsburg, Germany) presented new application examples for its robots in the medical technology sector at this year's MEDICA, the world's largest annual medical technology trade fair, which took place from 15-18 November in Düsseldorf, Germany. More...
At the 2021 edition of MEDICA, more than 5,000 exhibitors from 70 countries presented their newest products and ideas. The event also drew more than 120,000 trade visitors from over 170 countries.

KUKA is a supplier of intelligent automation solutions and offers robotic solutions for the medical and healthcare sectors. Robot systems from KUKA are suitable for a wide range of applications in robotic medical technology: from diagnosis and operations to rehabilitation. At MEDICA 2021, KUKA presented innovative ideas for robot-based applications in medicine, such as the collaborative LBR Med which is perfectly suited for various tasks in the medical field, thanks to its sensitive sensor technology. From diagnostics to treatment and surgical interventions – the LBR Med stands out as a perfect assistant for diverse tasks in the field of healthcare. The sensitive seven-axis lightweight robot is flexible and easy to integrate into medical products for various medical activities. With its responsive sensors, comprehensive safety precautions, hygiene-optimized surfaces and a controller designed for direct collaboration with the human operator, it is ideally suited to applications in medical technology.

KUKA demonstrated some of the possible applications of the LBR Med with the help of a medical feature cell, for example with an ultrasound-demo and a spine application. An ultrasound probe attached to the flange was guided over the body, and KUKA demonstrated how the robot records the path and then repeats the learned path independently and with constant pressure. It also demonstrated how the robot can take a change in the surface into account and continued to follow the path with the appropriate adjustment.

Additionally, KUKA’s long-time partner BEC presented guidoo - a robot-assisted surgical assistance system. The system is based on the LBR Med and enables safe and precise tissue removal during percutaneous interventions, i.e. the insertion of needles under the skin. This relieves doctors and minimizes collateral tissue damage.

Related Links:
KUKA AG


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
POC Helicobacter Pylori Test Kit
Hepy Urease Test
POC Immunoassay Analyzer
Procise DX
New
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Pathology

view channel
Image: Researchers evaluated AI models that quantify tumor-infiltrating lymphocytes (TIL) on routine breast tissue slides, where higher TIL levels reflect stronger antitumor response and improved breast cancer outcomes (Image Credit: Shutterstock)

AI Matches Pathologists in Predicting Breast Cancer Prognosis from Immune Cells

Breast cancer is the most common cancer in Australian women, with more than 20,000 cases each year. Prognosis can be informed by counting tumor-infiltrating lymphocytes (TILs) on routine pathology slides,... Read more

Industry

view channel
Image Credit: Adobe Stock

Companion Diagnostics Expand HER2 Testing in Metastatic Gastroesophageal Cancer

Gastroesophageal adenocarcinoma comprises a group of aggressive cancers that are often diagnosed at an advanced stage and carry poor prognoses. Gastric and esophageal cancers rank among the leading causes... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.